Can You Take HRT With Inflammatory Bowel Disease? What the Studies and Labels Say

Can you take HRT with inflammatory bowel disease? Often, yes. Crohn's disease and ulcerative colitis aren't on the estrogen label's list of reasons not to use it, and small studies found HRT didn't worsen IBD. The bigger question is blood clots: IBD raises clot risk, especially during flares, so the route, timing and your other risks matter.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

What we actually verified · Last verified October 2026

What we read on October 29, 2026:

• The studies of HRT in women who already have IBD (a 2008 University of Chicago study and a 2023 two-center study), a 2025 systematic review of menopause and IBD, and two large studies of whether HRT is linked to developing IBD (the US Nurses' Health Study and a 2025 Taiwan study).
• The largest study of blood clots during IBD flares and remission (Lancet, 2010), the 2021 international consensus on preventing clots in IBD, and a November 2025 gastroenterology review of IBD from puberty to menopause.
• Patient information from the Crohn's & Colitis Foundation, Crohn's & Colitis UK, the NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and MedlinePlus.
• The UK NICE menopause guideline (NG23), The Menopause Society's 2022 hormone therapy and 2023 nonhormone therapy position statements, and the FDA's 2021 safety communication on JAK inhibitors.
• FDA-approved labels on DailyMed for the Climara estradiol patch, Prometrium (progesterone), Xeljanz (tofacitinib), Rinvoq (upadacitinib), Veozah (fezolinetant), Lynkuet (elinzanetant) and duloxetine.

What we did not do: we are not clinicians, we did not treat anyone, and we did not interview patients. Nothing here is advice to start, stop or change any medicine, including your IBD medicines. Your gastroenterologist and your menopause clinician are the people who can make that call with you.

Our commercial interest: we may earn a commission if you start care with a provider featured in The HRT Index's Find My HRT Path tool. No provider is linked on this page, and that never changes what we report. How we make money.

How we judge any option (our Verification Standard, in this order): 1) clinical legitimacy, 2) care quality, 3) medication fit, 4) price transparency, 5) access. Read the full methodology.

Jump to: Quick answer by situation · Is IBD a contraindication? · Does HRT affect IBD? · Can HRT cause colitis? · Blood clots · Pill, patch, gel or vaginal · IBD medicines · Menopause or a flare? · Bones · When to see someone first · Non-hormonal options · Questions for your clinicians · Online care · FAQ

Can you take HRT with inflammatory bowel disease? A quick answer for your situation

Inflammatory bowel disease (IBD) mainly means Crohn's disease and ulcerative colitis. Both cause long-term inflammation in the digestive tract, according to the NIDDK. IBD is not the same as irritable bowel syndrome (IBS), which causes belly pain and bowel changes without visible damage to the gut. This page is about IBD.

Whether HRT fits depends less on the IBD label and more on how active your disease is right now, what you take for it, and your other clot risks.

The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. With IBD, some situations, like an active flare or a past clot, belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.

Is IBD a contraindication for HRT?

No, not on the label we checked. The FDA label for the Climara estradiol patch lists the conditions where estrogen should not be used:

• unexplained genital bleeding
• breast cancer, now or in the past, or another estrogen-dependent cancer
• an active or past deep vein thrombosis (DVT) or pulmonary embolism (PE)
• an active or past stroke or heart attack
• liver impairment or liver disease
• protein C, protein S or antithrombin deficiency, or another known clotting disorder
• a severe allergic reaction to the product

Crohn's disease and ulcerative colitis are not on that list. Crohn's & Colitis UK gives a similar list of reasons HRT may not be suitable, including a history or high risk of blood clots, uncontrolled high blood pressure and liver disease. It adds a point that matters for IBD: "Crohn's and Colitis can increase your risk of blood clots, especially if you're in a flare-up. Your doctor may be cautious of prescribing HRT if you have other risk factors for blood clots, such as a high body mass index (BMI)."

So IBD itself doesn't rule HRT out, but two IBD-related problems can. One is a past blood clot. The other is liver disease such as primary sclerosing cholangitis (PSC). The Crohn's & Colitis Foundation says about three-quarters of all people with PSC have IBD, and that it's more common with ulcerative colitis.

If you have a uterus, estrogen also needs a progestogen, such as progesterone, to protect the womb lining, as the Climara label explains. See do you need progesterone if you have a uterus. For everyone's general contraindications, see who should not take HRT.

Does HRT make Crohn's or ulcerative colitis worse?

The small studies we found point the other way: HRT was linked to less IBD activity, not more. But these are small, look-back studies, and none was a randomized trial.

Two cautions on reading these. First, even in the 2023 study, 9 of the 37 women (24%) still needed stronger IBD treatment within a year of starting HRT, so HRT is not a substitute for IBD treatment. Second, the HRT group in that study had worse disease before menopause than the comparison group, which makes the comparison harder to read.

What about progesterone? A 2022 review in Climacteric on progesterone and the gut says it "does not affect inflammatory bowel disease-specific symptoms," though it does slow how fast food moves through the gut. That fits with the 2023 study, where 30% of women used both hormones.

The short version: there is no good evidence that HRT makes established IBD worse, and some weak evidence it might help. HRT should not be started as a treatment for IBD.

Can HRT cause ulcerative colitis or Crohn's disease?

This is a different question from the one above. It's about women who don't have IBD yet, and the answer is mixed.

• The US Nurses' Health Study (2012) followed 108,844 postmenopausal women. Compared with women who never used hormones, current users had a 71% higher risk of developing ulcerative colitis (hazard ratio 1.71) and past users a 65% higher risk (1.65). The risk rose with longer use and fell after stopping. Estrogen alone and estrogen plus progestin looked the same. There was no clear link with Crohn's disease (1.19, not significant).
• A Taiwan study (2025) followed 10,126 postmenopausal women for about 11 years and found no significant link with either ulcerative colitis (hazard ratio 1.33) or Crohn's (0.72).
• The 2025 systematic review summed it up: some studies linked hormone therapy to more ulcerative colitis, while others found no significant link after adjusting for other factors.

It helps to see the absolute numbers. In the Taiwan study, ulcerative colitis was diagnosed in 0.14 per 1,000 women per year among HRT users and 0.11 per 1,000 among non-users. Even taking a "71% higher risk" at face value, a rare disease stays rare.

Researchers have suggested the gut route may matter. A 2016 review in Drug Safety notes that oral estrogen has been shown to change how permeable the gut lining is. That's a theory, not proof, and none of these studies compared pills with patches. The 2025 gastroenterology review also notes that these findings "pertain to incident IBD risk only," meaning they're about new cases, not about women who already have IBD.

Why blood clots are the main issue with IBD and HRT

If you remember one thing from this page, make it this. IBD raises the risk of blood clots in the veins (venous thromboembolism, or VTE), and oral estrogen raises it too. The two risks can add up.

How much IBD raises clot risk. The Crohn's & Colitis Foundation says people with IBD have about three times the risk of the general population for DVT or PE. The 2021 international consensus on clots in IBD, written by IBD experts, puts it at about twice the risk. Their consensus also says the risk is tied to disease activity and rises in hospital.

The largest study, in The Lancet in 2010, followed 13,756 people with IBD and 71,672 people without it. It shows how much timing matters:

In that study, a "flare" meant the 120 days after a new steroid prescription. Put simply, out of 1,000 people with IBD followed for a year, about 3 had a clot overall, and about 9 did during flares.

Where HRT fits. The international consensus lists hormone replacement therapy and estrogen-containing birth control pills among the "minor" risk factors for clots in people with IBD. The UK NICE menopause guideline says the risk of VTE "is increased with oral HRT" and "is not increased with transdermal HRT," meaning patches, gels and sprays. NICE recommends that clinicians "consider transdermal rather than oral HRT" for people at increased risk of VTE, including those with a BMI over 30. The Menopause Society says observational studies haven't shown higher clot risk with transdermal estrogen, but randomized trials are lacking. It also says micronized progesterone may be less likely to cause clots than other progestogens.

Surgery and hospital stays. The Climara label says that, if feasible, estrogen should be stopped at least 4 to 6 weeks before surgery that carries a higher clot risk, and during long periods of being immobile. With IBD, bowel surgery and hospital stays are part of life for some women, so your surgical team and HRT prescriber need to know about each other.

Clot-risk factors your clinicians will likely ask about

This checklist pulls together the risk factors named in the consensus, the estrogen label and NICE. It isn't a scoring tool, but having the answers ready makes the conversation faster.

For more on the general picture, see HRT and blood clots.

Pill, patch, gel or vaginal estrogen: which route fits IBD?

There's no IBD-specific HRT guideline that picks a route. But the clot data above, and the way pills pass through the gut and liver, are why many clinicians lean toward non-oral estrogen when IBD is in the picture.

About absorption. The best data on hormones and IBD absorption come from birth control, not HRT. The 2025 gastroenterology review notes that women with mild ulcerative colitis, ileostomies or small-bowel resections reached comparable ethinyl estradiol levels from birth control pills. It also says that "where rapid transit is a concern, nonoral routes, transdermal or vaginal, may be preferred." That advice was written about contraception, so treat it as a reasonable inference for HRT, not proof.

One IBD medicine's own label shows why this question comes up. The Rinvoq label warns that tablet residue has been seen in stool or ostomy output in people with shortened gut transit times. That's about Rinvoq, not estrogen, but it's the kind of thing to mention if you've had bowel surgery.

For a fuller comparison, see oral vs transdermal estrogen and estradiol patch vs pill.

IBD medicines and HRT: what to check

The 2025 gastroenterology review notes there are "no known drug interactions between hormonal contraceptives and IBD-specific therapies." That's about birth control, but it uses the same hormones as HRT. The bigger issues with IBD medicines are clot risk and bones, not interactions in the usual sense.

Menopause or an IBD flare? How the two overlap

Menopause and IBD can feel alike. Crohn's & Colitis UK lists menopause symptoms such as hot flushes, mood changes, brain fog and muscle and joint aches, and says some of them are similar to Crohn's and colitis symptoms. It suggests speaking to your IBD team if you're unsure which is which.

What the research says about menopause and IBD:

• Most women don't see a big change. Crohn's & Colitis UK says "for most people their Crohn's or Colitis symptoms are not affected by the menopause." In an internet-based group of women with IBD described in the 2025 gastroenterology review, 65% of women saw no change, 16% improved and 19% got worse.
• Menopause may come a little earlier. The 2025 systematic review found women with IBD reach menopause earlier than women without it. One study in the gastroenterology review found women with Crohn's reached menopause about 2 years earlier (48 vs 50). Crohn's & Colitis UK says it's not clear whether IBD affects menopause age, so the evidence isn't settled.
• Vaginal symptoms can be worse. The systematic review found women with IBD report more severe vulvovaginal symptoms.
• New gut symptoms need sorting out. The gastroenterology review notes menopause can slow gut motility, and that new symptoms need to be told apart from IBD activity. It also says urinary urgency, which is common in menopause, needs to be told apart from diarrhea.

If menopause comes early, HRT can matter more. The Menopause Society recommends hormone therapy for women with early menopause or primary ovarian insufficiency at least until the average age of menopause, about 52, unless there's a reason not to. See premature menopause vs premature ovarian insufficiency.

IBD is not IBS. If your gut symptoms are new and you don't have an IBD diagnosis, that's a different question. IBS is a disorder of how the gut and brain work together, with no visible damage to the gut, according to the NIDDK. Our page on menopause and bloating covers common menopause gut symptoms. Blood in your stool or weight loss you can't explain, both listed by the NIDDK as possible IBD symptoms, needs a doctor's assessment, not a menopause label.

IBD, menopause and your bones

This is one place where IBD and menopause add up in a way that can make estrogen more relevant, not less.

Crohn's & Colitis UK lists the IBD-related reasons for thinner bones: inflammation, steroids, low calcium and vitamin D, and having part of the small bowel removed. It also notes that osteoporosis risk rises as estrogen falls at menopause. The 2025 gastroenterology review says guidelines recommend bone density scans for perimenopausal women with IBD, or with other risk factors such as more than 3 months of steroids, a past fracture or very low BMI, regardless of age. It suggests calcium of 1,200 mg a day and vitamin D of at least 800 IU a day, and says IBD shouldn't be a reason to withhold osteoporosis treatment.

The Menopause Society says hormone therapy has been shown to prevent bone loss and fracture. For women under 60 or within 10 years of menopause with no contraindications, it calls the benefit-risk balance favorable for bothersome hot flashes and prevention of bone loss.

Ask your clinicians whether you've had a bone density scan, and whether bone protection changes the HRT conversation for you. See does HRT help osteoporosis and estrogen for bone density.

When to see someone in person first

Online menopause care may suit women whose IBD is stable. These situations belong with your gastroenterologist or another doctor in person before starting HRT:

• You're in an active flare, were recently in hospital, or are on a steroid course.
• You've had a DVT or PE, or have a known clotting disorder.
• You have PSC, cirrhosis or another liver disease.
• Bowel surgery is planned, or you've just had it.
• You take a JAK inhibitor and want to add estrogen.
• Unexplained vaginal bleeding, which is an estrogen contraindication until it's been checked.
• New gut symptoms that you haven't had assessed, such as blood in your stool or weight loss you can't explain.

Call 911 or go to an emergency room for possible clot symptoms. MedlinePlus lists sudden shortness of breath, fast breathing, chest pain that gets worse with a deep breath or cough, a fast heart rate, coughing up blood or fainting as possible signs of a PE. Pain, swelling, warmth or redness in one leg can be a DVT and needs urgent care.

What if HRT isn't right for you?

If estrogen is ruled out, for example after a blood clot, there are other options for hot flashes. The Menopause Society's 2023 nonhormone position statement recommends cognitive behavioral therapy, clinical hypnosis, SSRIs and SNRIs, gabapentin, fezolinetant (Veozah), and oxybutynin.

• Veozah (fezolinetant) and Lynkuet (elinzanetant) are newer non-hormonal pills. Both labels require liver blood tests before starting, with follow-up tests during treatment. Veozah is contraindicated with CYP1A2 inhibitors, which include the antibiotic ciprofloxacin. See the Veozah liver warning.
• Low-dose paroxetine (7.5 mg) is FDA-approved for hot flashes, and the statement also recommends other SSRIs and SNRIs and gabapentin.
• Vaginal symptoms can often be treated with low-dose vaginal estrogen even when systemic HRT isn't used, as the gastroenterology review notes. Ask whether that applies to you.

See non-hormonal hot flash medication online for a fuller comparison.

What should you ask your gastroenterologist and menopause clinician?

For your gastroenterologist:

1. Is my IBD in remission, and how would we know if it flared on HRT?
2. Do any of my IBD medicines raise my clot risk, especially if I add estrogen?
3. Is a steroid course likely in the next few months?
4. Do I have any liver involvement, such as PSC?
5. Is my bowel surgery or transit a reason to avoid pills?
6. When was my last bone density scan?

For your menopause clinician:

1. Given my IBD, would you start with a patch or gel rather than a pill? Why?
2. If I have a uterus, which progestogen would you use, and in what form?
3. Would vaginal estrogen help my symptoms, alone or with systemic HRT?
4. What should I do with my HRT if I'm admitted to hospital or need surgery?
5. Which symptoms should make me call you, and which should go to my IBD team?

A simple record helps both clinicians. For the first 3 months, jot down your hot flash and sleep symptoms, your bowel frequency and any bleeding, and any steroid courses or hospital visits. Bring it to each appointment.

Can you get HRT online if you have IBD?

You can, if your IBD is stable, you don't have a past clot or liver disease, and the service takes a full history, including your IBD medicines and any surgery. Online care is a poor starting point if you're mid-flare, recently in hospital, on a JAK inhibitor with other clot risks, or dealing with new, unexplained gut symptoms.

Look for a service where a licensed clinician reviews your IBD history and every medicine before prescribing, that offers patches, gels, vaginal and non-hormonal options rather than pills only, and that includes follow-up. It helps if they're willing to coordinate with your gastroenterologist.

Our guide to whether online HRT is safe covers the general checks. If you'd like help sorting out which kind of care fits your situation, Find My HRT Path asks about your symptoms, what you've tried, your age, your state and your health history. It then shows a featured care option, or tells you when in-person care is a better place to start. It's free, takes about 60 seconds and needs no email. It is not a diagnosis or a prescription decision.

Frequently asked questions

Can you take HRT if you have Crohn's disease or ulcerative colitis?

Often, yes. Neither is on the estrogen label's contraindication list, and a 2025 gastroenterology review found no evidence that IBD should affect the decision to start HRT. Blood clot risk, especially during flares, is the main thing to weigh, along with liver disease and your IBD medicines.

Does HRT make IBD flare?

The small studies we found suggest the opposite. In a 2008 study of 65 women, HRT was linked to fewer flares, and in a 2023 study of 37 women, moderate-to-severe disease fell from 32% to 8% after starting HRT. Neither was a randomized trial.

Can HRT cause ulcerative colitis?

The evidence is mixed. A large US study linked hormone use to a 71% higher risk of developing ulcerative colitis, but a 2025 Taiwan study found no significant link. Either way, ulcerative colitis stayed rare: about 0.14 cases per 1,000 HRT users a year in the Taiwan study.

Is the patch better than the pill if you have IBD?

Often, it's the route clinicians consider first. NICE says clot risk is increased with oral HRT but not with transdermal HRT, and suggests transdermal for people at higher clot risk. IBD raises clot risk, and a patch also avoids any question about gut absorption.

Is vaginal estrogen safe with IBD?

A 2025 gastroenterology review says low-dose vaginal estrogen has minimal absorption into the body, making it suitable for women with IBD who aren't on systemic HRT. Women with IBD also tend to report worse vaginal symptoms, so it's worth asking about.

Can you take HRT with a JAK inhibitor like Xeljanz or Rinvoq?

That's a decision for your gastroenterologist and menopause clinician together. Both labels carry a boxed warning for blood clots and say to avoid the drug in people at increased clot risk. The Rinvoq label found Rinvoq didn't meaningfully change ethinyl estradiol levels from a birth control pill.

Does menopause make Crohn's or colitis worse?

For most women, no. Crohn's & Colitis UK says most people's symptoms aren't affected by menopause. In one survey, 65% saw no change, 16% improved and 19% got worse. New symptoms should still be checked by your IBD team.

The bottom line

Inflammatory bowel disease doesn't rule out HRT. Crohn's and ulcerative colitis aren't estrogen contraindications, and the small studies we found suggest HRT doesn't worsen IBD and may even go along with fewer flares. The real issue is blood clots. IBD raises clot risk, especially during flares and hospital stays, so the timing, the route and your other risk factors matter. That's why many women with IBD discuss a patch or gel rather than a pill, and why a past clot, liver disease or a JAK inhibitor calls for a joint decision with your gastroenterologist. Bones are a reason to have the conversation sooner, not later.

If you're not sure where your care should begin, Find My HRT Path can help you see a featured option or flag when in-person care is the better first step.

Related reading

• HRT and blood clots
• HRT after a blood clot
• Oral vs transdermal estrogen
• Who should not take HRT
• HRT and liver disease
• Is vaginal estrogen safe long term?
• HRT and rheumatoid arthritis
• Can you take HRT if you are overweight?

Sources

All sources were read on October 29, 2026.

1. Kane SV, Reddy D. Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease. American Journal of Gastroenterology, 2008;103(5):1193–1196. https://pubmed.ncbi.nlm.nih.gov/18177456/
2. Freeman M, et al. Hormone replacement therapy is associated with disease activity improvement among post-menopausal women with inflammatory bowel disease. Journal of Clinical Medicine, 2023;13(1):88. https://pmc.ncbi.nlm.nih.gov/articles/PMC10779540/
3. Kale T, et al. Menopause and inflammatory bowel disease: a systematic review. Inflammatory Bowel Diseases, 2025;31(12):3443–3449. https://pmc.ncbi.nlm.nih.gov/articles/PMC12688076/
4. Ghoneim S, Kochar B. Understanding inflammatory bowel disease in women from puberty to menopause. Gastroenterology & Hepatology, 2025;21(11). https://www.gastroenterologyandhepatology.net/archives/november-2025/understanding-inflammatory-bowel-disease-in-women-from-puberty-to-menopause/
5. Coquoz A, et al. Impact of progesterone on the gastrointestinal tract: a comprehensive literature review. Climacteric, 2022;25(4):337–361. https://pubmed.ncbi.nlm.nih.gov/35253565/
6. Khalili H, et al. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology, 2012;143(5):1199–1206. https://pmc.ncbi.nlm.nih.gov/articles/PMC3480540/
7. Tseng YT, et al. Association of hormone replacement therapy with inflammatory bowel disease risk in women with menopausal disorders: a population-based retrospective cohort study. Healthcare (Basel), 2025;13(5):578. https://pmc.ncbi.nlm.nih.gov/articles/PMC11899444/
8. Khalili H. Risk of inflammatory bowel disease with oral contraceptives and menopausal hormone therapy: current evidence and future directions. Drug Safety, 2016;39(3):193–197. https://pubmed.ncbi.nlm.nih.gov/26658991/
9. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. The Lancet, 2010;375(9715):657–663. https://pubmed.ncbi.nlm.nih.gov/20149425/
10. Olivera PA, et al. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology, 2021;18(12):857–873. https://www.nature.com/articles/s41575-021-00492-8
11. Crohn's & Colitis Foundation. The facts about inflammatory bowel diseases. https://www.crohnscolitisfoundation.org/sites/default/files/2019-02/Updated IBD Factbook.pdf
12. Crohn's & Colitis UK. Reproductive health and fertility. https://www.crohnsandcolitis.org.uk/media/1znghanl/reproductive-health-ed-2b-2024-no-refs.pdf
13. National Institute of Diabetes and Digestive and Kidney Diseases. Crohn's disease. https://www.niddk.nih.gov/health-information/digestive-diseases/crohns-disease
14. National Institute of Diabetes and Digestive and Kidney Diseases. Ulcerative colitis. https://www.niddk.nih.gov/health-information/digestive-diseases/ulcerative-colitis
15. National Institute of Diabetes and Digestive and Kidney Diseases. Definition and facts for irritable bowel syndrome. https://www.niddk.nih.gov/health-information/digestive-diseases/irritable-bowel-syndrome/definition-facts
16. MedlinePlus. Pulmonary embolism. https://medlineplus.gov/pulmonaryembolism.html
17. MedlinePlus. Deep vein thrombosis. https://medlineplus.gov/deepveinthrombosis.html
18. National Institute for Health and Care Excellence. Menopause: identification and management (NG23), recommendations. https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
19. The Menopause Society. The 2022 hormone therapy position statement. https://menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf
20. The Menopause Society. The 2023 nonhormone therapy position statement. https://menopause.org/wp-content/uploads/professional/2023-nonhormone-therapy-position-statement.pdf
21. US Food and Drug Administration. FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions (2021). https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-warnings-about-increased-risk-serious-heart-related-events-cancer-blood-clots-and-death
22. Climara (estradiol transdermal system) prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e9702c4-f2d7-4ea8-b6e8-7dca31671864
23. Prometrium (progesterone capsules) prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1cf237ff-c4f8-4faa-a7aa-77599c856889
24. Xeljanz (tofacitinib) prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=68e3d6b2-7838-4d2d-a417-09d919b43e13
25. Rinvoq (upadacitinib) prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2966aec7-2ef0-923c-d8ff-fe1a957bf095
26. Veozah (fezolinetant) prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cae9f798-24f9-4580-a4fc-e6c710cbda3c
27. Lynkuet (elinzanetant) prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f42884ff-7dff-419c-8a0c-affe2ed73818
28. Duloxetine delayed-release capsules prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a105a648-6a97-4151-b9de-d7eac90a8f79

This page is for education only. It is not medical advice and does not replace care from your own clinicians.